BRC Operations Pty. Ltd.
Quick facts
Marketed products
- Short Acting Methylphenidate · Neurology; Psychiatry
Short-acting methylphenidate blocks the reuptake of dopamine and norepinephrine in the central nervous system, increasing their availability at the synapse.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: